+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189458
  • Report
  • October 2020
  • Region: Global
  • 380 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • 3M Co
  • Cassava Sciences Inc
  • Extend Biosciences Inc
  • MedRx, Inc.
  • Radius Health Inc
  • TheraSolve NV (Inactive)
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020“. Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Co
  • Cassava Sciences Inc
  • Extend Biosciences Inc
  • MedRx, Inc.
  • Radius Health Inc
  • TheraSolve NV (Inactive)

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transdermal Drug Delivery Overview
3 Products under Development
3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery - Pipeline Products by Segment
3.3 Transdermal Drug Delivery - Pipeline Products by Territory
3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery - Ongoing Clinical Trials
4 Transdermal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development
5 Transdermal Drug Delivery Companies and Product Overview6 Transdermal Drug Delivery- Recent Developments 2977 Appendix
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
List of Tables
Table 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table 2: Transdermal Drug Delivery - Pipeline Products by Segment
Table 3: Transdermal Drug Delivery - Pipeline Products by Territory
Table 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Transdermal Drug Delivery - Ongoing Clinical Trials
Table 7: Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Table 9: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 10: 3M Hollow Microstructured Transdermal System - Product Status
Table 11: 3M Hollow Microstructured Transdermal System - Product Description
Table 12: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: 4P Clonidine Transdermal Patch - Product Status
Table 14: 4P Clonidine Transdermal Patch - Product Description
Table 15: 4P Lidocaine Transdermal Patch - Product Status
Table 16: 4P Lidocaine Transdermal Patch - Product Description
Table 17: 4P Scopolamine Transdermal Patch - Product Status
Table 18: 4P Scopolamine Transdermal Patch - Product Description
Table 19: Aversa - Product Status
Table 20: Aversa - Product Description
Table 21: Transdermal Apomorphine Patch - Product Status
Table 22: Transdermal Apomorphine Patch - Product Description
Table 23: Transdermal Exenatide Patch - Product Status
Table 24: Transdermal Exenatide Patch - Product Description
Table 25: Transdermal FSH Patch - Product Status
Table 26: Transdermal FSH Patch - Product Description
Table 27: Transdermal Patch - Chronic Pain - Product Status
Table 28: Transdermal Patch - Chronic Pain - Product Description
Table 29: Transdermal Patch - Diabetes - Product Status
Table 30: Transdermal Patch - Diabetes - Product Description
Table 31: Transdermal Patch - Migraine - Product Status
Table 32: Transdermal Patch - Migraine - Product Description
Table 33: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: GentleDispense System - Product Status
Table 35: GentleDispense System - Product Description
Table 36: Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: PHN Patch - Product Status
Table 38: PHN Patch - Product Description
Table 39: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: AQS1301 - Product Status
List of Figures
Figure 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
Figure 2: Transdermal Drug Delivery - Pipeline Products by Segment
Figure 3: Transdermal Drug Delivery - Pipeline Products by Territory
Figure 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
Figure 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
Figure 6: Transdermal Drug Delivery - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3M Co
  • 4P Therapeutics LLC
  • Actuated Medical Inc
  • Adynxx Inc
  • Aequus Pharmaceuticals Inc
  • Agile Therapeutics Inc
  • Allergan Ltd
  • AMW GmbH
  • AngioSoma Inc
  • Apogee Technology Inc
  • Asahi Kasei Pharma Corp
  • ASCIL Biopharm
  • Avecho Biotechnology Ltd
  • Avro Life Sciences
  • Boryung Pharmaceutical Co Ltd
  • Burke Pharmaceuticals LLC
  • Candesant Biomedical Inc
  • Cassava Sciences Inc
  • CB Scientific Inc
  • Cerimon Pharmaceuticals, Inc. (Inactive)
  • Chrono Therapeutics Inc
  • Cipla Ltd
  • Clexio Biosciences Ltd
  • Corium Inc
  • Daewoong Pharmaceutical Co Ltd
  • DBV Technologies SA
  • DD Therapeutics LLC
  • Delpor Inc
  • Dermisonics Inc (Inactive)
  • Dharma Therapeutics, Inc. (Inactive)
  • Diomics Corp
  • Drexel University
  • DURECT Corp
  • Echo Therapeutics Inc
  • Emplicure AB
  • Endo International Plc
  • Extend Biosciences Inc
  • Fe3 Medical Inc
  • Futura Medical Plc
  • Georgia Institute of Technology
  • Georgia State University
  • Hisamitsu Pharmaceutical Co Inc
  • I M Sechenov Moscow State Medical University
  • Icure Pharmaceutical Inc
  • ImmuPatch
  • Indian Institute of Science
  • Indian Institute of Technology Bombay
  • InMed Pharmaceuticals Inc
  • Institute of Materials Research & Engineering
  • Intercell AG (Inactive)
  • Interstitial NS
  • Isis Biopolymer Inc (Inactive)
  • Janisys
  • KTH Royal Institute of Technology
  • Leo Pharma AS
  • Livzon Pharmaceutical Group Co Ltd
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Massachusetts Institute of Technology
  • Mayne Pharma Group Ltd
  • Medherant Ltd
  • MEDRx Co Ltd
  • MedRx, Inc.
  • Microdermics Inc
  • Micron Biomedical Inc
  • Micropoint Technologies Pte Ltd
  • mPhase Technologies Inc
  • National University of Singapore
  • Nemaura Pharma Ltd
  • NeuroDerm Ltd
  • Nitto Denko Corp
  • North Carolina State University
  • Noven Pharmaceuticals Inc
  • NutriBand Inc
  • Nuvo Pharmaceuticals Inc
  • PassPort Technologies Inc
  • Privo Technologies Inc
  • Prometheon Pharma LLC
  • Purdue University
  • Quoin Pharmaceuticals Ltd
  • Radius Health Inc
  • Ryah Medtech Inc
  • Samyang Biopharmaceuticals Corp
  • Scilex Ltd
  • Seelos Therapeutics, Inc.
  • Shenox Pharmaceuticals LLC
  • Sinsin Pharmaceutical Co Ltd
  • SK Chemicals Co Ltd
  • Skinject Inc
  • Sparsha Pharma International Pvt Ltd
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • Starton Therapeutics Inc
  • Syntropharma Ltd
  • Taho Pharmaceuticals Ltd
  • Technology Health Inc
  • Teikoku Pharma USA Inc
  • tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd
  • Texas Tech University
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TheraJect Inc
  • Therapeutic Systems Research Laboratories Inc
  • TheraSolve NV (Inactive)
  • Theratech, Inc.
  • Thrudermic LLC
  • Titan Pharmaceuticals Inc
  • Toa Eiyo Ltd
  • Transcu Group Limited (Inactive)
  • Transdermal Delivery Solutions Corp
  • Transdermal Specialties Inc
  • TransPharma Medical Ltd (Inactive)
  • Transport Pharmaceuticals Inc
  • University of Illinois at Chicago
  • University of Toronto
  • Vaxess Technologies Inc
  • Vaxxas Pty Ltd
  • Verndari Inc
  • ViiV Healthcare UK Ltd
  • Virpax Pharmaceuticals Inc
  • Vyteris, Inc. (Inactive)
  • Xel Pharmaceuticals Inc
  • XPhyto Therapeutic Corp
  • Zambon Italia Srl
  • Z-Cube Srl
  • ZetrOZ Inc
  • Zynerba Pharmaceuticals Inc
Note: Product cover images may vary from those shown